1 documents found
Information × Registration Number 0207U006030, 0104U006074 , R & D reports Title Creation of technology of highly purified plasminogen obtaining and validation of its application as thromobolytic preparation for intravascular thromboses treatment popup.stage_title Head Kudinov S.A., Registration Date 12-03-2007 Organization Palladin Institute Biochemastry of National Academy of Sciences of Ukraine popup.description2 In the present work the mechanisms of fibrinolytic potential elevation at trombogenic diseases, which are the result of complication during tumor eye tissue development, has been studied. The elevation of Pg concentration in human blood in the presence of coagulation components and at the sufficient t-PA concentration, directly enhances the activation process and increases the fibrinolysis velocity. So, till the development of the main disease is fibrinolytic potential, the risk of thrombus formation is negligiable. The natural activation of fibrinolysis system at the stimulation of acute inflammation processes and the suppression of this system under state of chronic inflammation is the base for further study of disbalance proteins of acute phase at thrombogenic disease. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Head: Kudinov S.A.. Creation of technology of highly purified plasminogen obtaining and validation of its application as thromobolytic preparation for intravascular thromboses treatment. (popup.stage: ). Palladin Institute Biochemastry of National Academy of Sciences of Ukraine. № 0207U006030
1 documents found

Updated: 2026-03-25